Impact of diltiazem administration and cyclosporine levels on the incidence of acute rejection in heart transplant patients-Reference-Cited by-同舟云学术

Impact of diltiazem administration and cyclosporine levels on the incidence of acute rejection in heart transplant patients

Published:2003-09 Issue:9 Volume:16 Page:676-680
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:Transplant Int

Author:

Delgado Juan F.,Sanchez Violeta,Calzada Carlos S.,Gomez-Sanchez Miguel A.,Escribano Pilar,Cea-Calvo Luis,Pascual Jacinto Garcia,Camara Agustin Gomezde,Sotelo Teresa,Rufilanchas Juan J.

Publisher

Frontiers Media SA

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1432-2277.2003.tb00369.x/fullpdf

Reference19 articles.

1. The registry of the international society for heart and lung transplantation: eighteenth official report—2001

2. Increased Incidence of Lymphoproliferative Disorder after Immunosuppression with the Monoclonal Antibody OKT3 in Cardiac-Transplant Recipients

3. Clinical outcomes after the arterial switch operation for transposition. Patient, support, procedural, and institutional risk factors. Congenital Heart Surgeons Society.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of hypertension in heart transplant recipients: an ongoing conundrum;Current Opinion in Cardiology;2024-03-28

2. Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation;The Journal of Heart and Lung Transplantation;2015-08

3. Should We Consider Heart Rate Reduction in Cardiac Transplant Recipients?;Clinical Cardiology;2012-08-21

4. Hypertension after pediatric cardiac transplantation: Detection, etiology, implications and management;Pediatric Transplantation;2009-07-16

5. Combination use of immune complexes and a Ca2+ channel blocker azelnidipine enhances interleukin-12 p40 secretion without T helper type 17 cytokine secretion in human monocyte-derived dendritic cells;Clinical and Experimental Immunology;2009-02-18